Analysed LANTHEUS HOLDINGS INC (LNTH:NASDAQ) News Sources
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
14-08-2026
yahoo.com
Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs
22-09-2026
yahoo.com
Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
28-09-2026
yahoo.com
What is the current price of LANTHEUS HOLDINGS INC (LNTH:NASDAQ)?
The current price of LANTHEUS HOLDINGS INC (LNTH:NASDAQ) is $100.15.
LANTHEUS HOLDINGS INC (LNTH:NASDAQ) absolute price change since previous trading day?
The absolute price change of LANTHEUS HOLDINGS INC (LNTH:NASDAQ) since the previous trading day is $0.03.
LANTHEUS HOLDINGS INC (LNTH:NASDAQ) percentage price change since previous trading day?
The percentage price change of LANTHEUS HOLDINGS INC (LNTH:NASDAQ) since the previous trading day is 0.03%.
What is the most recent average sentiment score for LANTHEUS HOLDINGS INC (LNTH:NASDAQ)?
The most recent average sentiment score for LANTHEUS HOLDINGS INC (LNTH:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for LANTHEUS HOLDINGS INC (LNTH:NASDAQ)?
The most recent sentiment for LANTHEUS HOLDINGS INC (LNTH:NASDAQ) is .
SEC-8K** Filing Available For LANTHEUS HOLDINGS INC (LNTH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.